These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 27726307)

  • 1. High prevalence of diabetes-specific autoimmunity in first-degree relatives of Sardinian patients with type 1 diabetes.
    Incani M; Serafini C; Satta C; Perra L; Scano F; Frongia P; Ricciardi R; Ripoli C; Soro M; Strazzera A; Zampetti S; Buzzetti R; Cavallo MG; Cossu E; Baroni MG
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27726307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of humoral autoimmunity in first-degree relatives of Mexican type 1 diabetes patients.
    Segovia-Gamboa NC; Rodríguez-Arellano ME; Muñoz-Solís A; Retana-Jiménez JE; Vargas-Ayala G; Granados J; Jiménez-Sánchez M; Sanchez-Torres C
    Acta Diabetol; 2018 Dec; 55(12):1275-1282. PubMed ID: 30306407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes.
    Redondo MJ; Babu S; Zeidler A; Orban T; Yu L; Greenbaum C; Palmer JP; Cuthbertson D; Eisenbarth GS; Krischer JP; Schatz D;
    J Clin Endocrinol Metab; 2006 May; 91(5):1705-13. PubMed ID: 16464953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
    Alves LI; Davini E; Correia MR; Fukui RT; Santos RF; Cunha MR; Rocha DM; Volpini WM; Silva ME
    J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated Progression to Type 1 Diabetes in the Presence of
    Balke EM; Balti EV; Van der Auwera B; Weets I; Costa O; Demeester S; Abrams P; Casteels K; Coeckelberghs M; Tenoutasse S; Keymeulen B; Pipeleers DG; Gorus FK;
    Diabetes Care; 2018 May; 41(5):1076-1083. PubMed ID: 29545461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.
    Ziegler AG; Pflueger M; Winkler C; Achenbach P; Akolkar B; Krischer JP; Bonifacio E
    J Autoimmun; 2011 Aug; 37(1):3-7. PubMed ID: 21376535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of children with type 1 diabetes in Korea: high prevalence of specific anti-islet autoantibodies, immunogenetic similarities to Western populations with "unique" haplotypes, and lack of discrimination by aspartic acid at position 57 of DQB.
    Yu J; Shin CH; Yang SW; Park MH; Eisenbarth GS
    Clin Immunol; 2004 Dec; 113(3):318-25. PubMed ID: 15507397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of enterovirus infections, autoimmune factors and HLA genotypes in patients with T1DM.
    Çekin Y; Özkaya E; Gülkesen H; Akçurin S; Çolak D
    Minerva Endocrinol; 2014 Mar; 39(1):67-74. PubMed ID: 24513606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study.
    Velluzzi F; Secci G; Sepe V; Klersy C; Shattock M; Foxon R; Songini M; Mariotti S; Locatelli M; Bottazzo GF; Loviselli A;
    Acta Diabetol; 2016 Feb; 53(1):73-9. PubMed ID: 25896008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals.
    Schlosser M; Strebelow M; Wassmuth R; Arnold ML; Breunig I; Rjasanowski I; Ziegler B; Ziegler M
    J Clin Endocrinol Metab; 2002 May; 87(5):2254-61. PubMed ID: 11994372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies in type 1 diabetes.
    Taplin CE; Barker JM
    Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
    Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
    Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.
    Michels A; Zhang L; Khadra A; Kushner JA; Redondo MJ; Pietropaolo M
    Pediatr Diabetes; 2015 Nov; 16(7):465-84. PubMed ID: 26202050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity.
    Hermann R; Laine AP; Veijola R; Vahlberg T; Simell S; Lähde J; Simell O; Knip M; Ilonen J
    Diabetologia; 2005 Sep; 48(9):1766-75. PubMed ID: 16025255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
    Zheng C; Zhou Z; Yang L; Lin J; Huang G; Li X; Zhou W; Wang X; Liu Z
    Diabetes Metab Res Rev; 2011 Jan; 27(1):70-8. PubMed ID: 21218510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    Barker JM; Barriga KJ; Yu L; Miao D; Erlich HA; Norris JM; Eisenbarth GS; Rewers M;
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3896-902. PubMed ID: 15292324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.
    Jin P; Huang G; Lin J; Yang L; Xiang B; Zhou W; Zhou Z
    Clin Endocrinol (Oxf); 2011 May; 74(5):587-92. PubMed ID: 21470281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity.
    Huang W; Connor E; Rosa TD; Muir A; Schatz D; Silverstein J; Crockett S; She JX; Maclaren NK
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2559-63. PubMed ID: 8675578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.